A reader searched Google using the following keywords
The reader then clicked on the following headline in Google Search
"The results of this study should change the way we treat patients with Alzheimer's disease. Cholinesterase inhibitors are approved for use in mild to moderate dementia, while memantine has been approved for advanced dementia. But it looks like there is an advantage in prescribing both drugs (Aricept and Namenda) as initial treatment."--John Growdon, MD
I would also like to direct your attention to this more recent article
Forest Laboratories, Inc. has announced that it plans to discontinue the sale of NAMENDA® (memantine HCl) 5 mg and 10 mg tablets effective August 15, 2014.
You will find several useful links at the bottom of that article, and also in the section labeled -
Related Articles in the Alzheimer's Reading Room.